Identification of germline genetic mutations in patients with pancreatic cancer-Reference-Cited by-同舟云学术

Identification of germline genetic mutations in patients with pancreatic cancer

Published:2015-10-06 Issue:24 Volume:121 Page:4382-4388
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Salo-Mullen Erin E.¹,O'Reilly Eileen M.¹,Kelsen David P.¹,Ashraf Asad M.¹,Lowery Maeve A.¹,Yu Kenneth H.¹,Reidy Diane L.¹,Epstein Andrew S.¹,Lincoln Anne¹,Saldia Amethyst¹,Jacobs Lauren M.¹,Rau-Murthy Rohini¹,Zhang Liying²,Kurtz Robert C.¹,Saltz Leonard¹,Offit Kenneth¹,Robson Mark E.¹,Stadler Zsofia K.¹

Affiliation:

1. Department of Medicine; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College; New York New York

2. Department of Pathology; Memorial Sloan Kettering Cancer Center; New York New York

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference28 articles.

1. Hereditary pancreatic adenocarcinoma: a clinical perspective;Brand;Med Clin North Am.,2000

2. Frequency of a family history of pancreatic malignancy in patients with pancreatic malignancy;Norton;Pancreas.,1998

3. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary;Asperen;J Med Genet.,2005

4. Breast Cancer Linkage Consortium. Cancer incidence in BRCA1 mutation carriers;Thompson;J Natl Cancer Inst.,2002

5. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program;Brose;J Natl Cancer Inst.,2002

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients.;European Journal of Cancer;2024-09

2. High frequency of germline variants in CFTR identified in PDAC patients enrolled in an expanded panel multi-gene panel testing program;HPB;2024-08

3. Integration of Germline Genetic Testing Into Routine Clinical Practice for Patients With Pancreatic Adenocarcinoma;JCO Oncology Practice;2024-07-18

4. Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia;JCO Precision Oncology;2024-06

5. Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC);Familial Cancer;2024-04-04